Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $287.85 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed an increase of +2,450.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2005 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $287.85 million | Fiscal year 2024: $11.29 million | Fiscal year 2023: $14.69 million | Fiscal year 2022: $9.60 million | Fiscal year 2021: $34.89 million | Fiscal year 2020: $32.67 million | Fiscal year 2019: $3.90 million | Fiscal year 2018: $4.26 million | Fiscal year 2017: $6.14 million | Fiscal year 2016: $3.20 million | Fiscal year 2015: $5.57 million | Fiscal year 2014: $8.03 million | Fiscal year 2013: $1.73 million | Fiscal year 2012: $170.1 thousand | Fiscal year 2011: $1.55 million | Fiscal year 2010: $3.38 million | Fiscal year 2009: $3.18 million | Fiscal year 2005: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: